financetom
Business
financetom
/
Business
/
Apple finds little sympathy from German judges in antitrust appeal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple finds little sympathy from German judges in antitrust appeal
Jan 28, 2025 7:07 AM

KARLSRUHE, Germany (Reuters) - German federal judges indicated on Tuesday that they could back the country's antitrust regulator in a legal battle with Apple ( AAPL ), following over three hours of deliberations over whether the U.S. tech giant should be subject to additional controls.

The German cartel office said in April 2023 it considered Apple ( AAPL ) a "company of paramount cross-market significance for competition", opening the door to possible measures curbing its dominance.

Wolfgang Kirchhoff, presiding judge on the panel assessing Apple's ( AAPL ) appeal against the designation, said an overall assessment had shown it could be true that Apple ( AAPL ) has such significance across markets.

However, the Federal Court of Justice held off on handing down a ruling on Tuesday, calling for more time to deliberate.

The legal team representing Apple ( AAPL ) urgently called on the court to consult with the European Court of Justice in Luxembourg before taking a decision, arguing that German law may not be in line with EU law on the issue.

Kirchhoff had said in his opening comments that the judges saw no grounds for a referral to the EU court.

If confirmed, Apple ( AAPL ) would join Google parent Alphabet and Facebook owner Meta as companies subject to extra controls in Germany over their "paramount cross-market significance".

(Reporting by Ursula Knapp, writing by Rachel More, editing by Thomas Seythal)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aclara Resources Raising US$25 Million in Private Placement
Aclara Resources Raising US$25 Million in Private Placement
Dec 23, 2024
09:04 AM EST, 12/23/2024 (MT Newswires) -- Aclara Resources ( ARAAF ) said Monday that it is raising US$25 million in a private placement to develop its Carina project in Brazil. The company said it also plans to use the funds to advance its integrated supply chain strategy, and for general corporate purposes. Under the financing, Aclara issued 51,303,573 shares...
CIBC Comments on Canada's GDP Data
CIBC Comments on Canada's GDP Data
Dec 23, 2024
09:00 AM EST, 12/23/2024 (MT Newswires) -- The Canadian economy appears to have been on a stronger footing than initially expected entering Q4, although early evidence for November suggests momentum has waned again, said CIBC. October's gross domestic product posted a healthy 0.3% month-over-month advance, which was a tick above the consensus and two ticks better than the early estimate...
Agnico Acquires 15% Stake in ONGold Resources, Participates in White Gold Financing
Agnico Acquires 15% Stake in ONGold Resources, Participates in White Gold Financing
Dec 23, 2024
09:02 AM EST, 12/23/2024 (MT Newswires) -- Agnico Eagle Mines ( AEM ) said Monday it has acquired 8.7 million shares of ONGold Resources ( ONGRF ) , which translates to 15% of the company on a non-diluted basis. The two companies signed an investor rights agreement, with ONGold granting Agnico Eagle certain rights to maintain its pro rata ownership...
Gain Therapeutics Says Australia Approves Start of Phase 1b Parkinson's Disease Study
Gain Therapeutics Says Australia Approves Start of Phase 1b Parkinson's Disease Study
Dec 23, 2024
09:00 AM EST, 12/23/2024 (MT Newswires) -- Gain Therapeutics ( GANX ) said Monday it has received approval in Australia to start a phase 1b trial of GT-02287, the company's lead allosteric small molecule in clinical development to treat Parkinson's disease with or without a GBA1 mutation. The main objective of the phase 1b trial is to evaluate the safety...
Copyright 2023-2026 - www.financetom.com All Rights Reserved